Abstract P3-14-08: Preclinical efficacy of targeting c-MET by ARQ197 in combination with PARP inhibitor plus standard cytotoxic agent in triple-negative breast cancer cell lines
2016 ◽
2014 ◽
Vol 149
(1)
◽
pp. 81-89
◽
2011 ◽
2017 ◽
Keyword(s):